View More Recent Stories
-
Ideaya Biosciences (IDYA) PT Raised to $61 at RBC Capital
-
IDEAYA Biosciences (IDYA) Prices 7.23M Share Offering at $35/sh
-
2Q24 U.S. biotech earnings preview
-
IDEAYA Biosciences (IDYA) Announces Proposed $200M Share and Warrant Offering
-
Citi Reiterates Buy Rating on Ideaya Biosciences (IDYA)
-
Ideaya Biosciences (IDYA) PT Raised to $62 at BTIG
-
Ideaya Biosciences (IDYA) PT Raised to $60 at Oppenheimer
-
Mizuho Starts Ideaya Biosciences (IDYA) at Outperform
-
IDEAYA Biosciences (IDYA) Announces Resignation of Chief Legal Officer
-
IDEAYA Biosciences (IDYA) Issues Clinical Program Updates for IDE397


